The cost implications of first anniversary renal function after living, standard criteria deceased and expanded criteria deceased donor kidney transplantation

Journal of Medical Economics

Volumn 16, Issue 1, 2013, Pages 75-84

  Schnitzler, Mark A ^a   Gheorghian, Adrian ^a   Axelrod, David ^b   L'italien, Gilbert ^c,d   Lentine, Krista L ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Billing claims; Glomerular filtration rate; Healthcare costs; Kidney transplantation; Medicare

Indexed keywords

ADULT; ARTICLE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEALTH CARE COST; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MEDICARE;

ADULT; AGE FACTORS; CONTINENTAL POPULATION GROUPS; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH EXPENDITURES; HUMANS; KIDNEY TRANSPLANTATION; MALE; MEDICARE; MIDDLE AGED; SEX FACTORS; TIME FACTORS; TISSUE DONORS; UNITED STATES;

EID: 84870881756     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/13696998.2012.722571     Document Type: Article

References (29)

1. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-305
2. Smith DH, Gullion CM, Nichols G, et al. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 2004;15:1300-6 (Pubitemid 38526011)
3. Lentine KL, Xiao H, Machnicki G, et al. Renal function and healthcare costs in patients with polycystic kidney disease. Clin J Am Soc Nephrol 2010;5:1471
4. Gill JS, Tonelli M, Mix CH, et al. The change in allograft function among longterm kidney transplant recipients. J Am Soc Nephrol 2003;14:1636-42 (Pubitemid 36687067)
5. Schnitzler MA, Whiting JF, Brennan DC, et al. The expanded criteria donor dilemma in cadaveric renal transplantation. Transplantation 2003;75:1940-5 (Pubitemid 36793272)
6. Schnitzler MA, Johnston K, Axelrod D, et al. Associations of renal function at 1-year after kidney transplantation with subsequent return to dialysis, mortality, and healthcare costs. Transplantation 2011;91:1347-56
7. United States Renal Data System. Researcher's Guide to the United States Renal Data System Database, 2010. Available at: Http://www.usrds.org/ 2010/rg/fb/index.html. Accessed July 7, 2012
8. Whiting JF, Woodward RS, Zavala EY, et al. Economic cost of expanded criteria donors in cadaveric renal transplantation: Analysis of Medicare payments. [see comment]. Transplantation 2000;70:755-60
9. United Network for Organ Sharing (UNOS) UNOS Policy 3.5.1 Definition of Expanded Criteria Donor and Standard Donor. [cited December 4, 2007]. http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/policy-7.pdf. Accessed July 7, 2012
10. Levey AS, Greene T, Kusek JW, et al. A simplified equation to prediction glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11:155A
11. Poggio ED, Wang X, Weinstein DM, et al. Assessing glomerular filtration rate by estimation equations in kidney transplant recipients. Am J Transplant 2006;6:100-8 (Pubitemid 43382207)
12. Gheorghian A, Schnitzler MA, Axelrod D, et al. The implications of acute rejection and reduced allograft function on health care expenditures in contemporary US kidney transplantation. Transplantation 2012;94:241-9
13. Lentine KL, Gheorghian A, Axelrod D, et al. The implications of acute rejection for allograft survival in contemporary U.S. kidney transplantation. Transplantation 2012;94(4):369-76
14. Bureau of Labor Statistics. Consumer Price Index 2003, US Average Medical Care. http://data.bls.gov/PDQ/servlet/SurveyOutputServlet. Accessed July 11, 2011
15. Schoenberg IJ. Contributions to the problem of approximation of equidistant data by analytic functions. Quart Appl Math 1946;4:45-99, 112-41
16. Ruppert D, Wand MP, Carroll RJ. Semiparametric Regression. Cambridge: Cambridge Series in Statistical and Probabilistic Mathematics. 2003
17. Wolfe RA, McCullough KP, Schaubel DE, et al. Calculating life years from transplant (LYFT): Methods for kidney and kidney-pancreas candidates. Am J Transplant 2008;8:997-1011 (Pubitemid 351389067)
18. Sinha R, Saad A, Marks SD. Prevalence and complications of chronic kidney disease in paediatric renal transplantation: A K/DOQI perspective. Nephrol Dial Transplant 2010;25:1313-20
19. Costa de Oliveira CM, Mota MU, Mota RS, et al. Prevalence and staging of chronic kidney disease in renal transplant recipients. Clin Transplant 2009; 23:628-36
20. Jimenez Alvaro S, Marcen R, Teruel JL, et al. Management of chronic kidney disease after renal transplantation: Is it different from nontransplant patients? Transplant Proc 2009;41:2409-11
21. Lefebvre P, Duh MS, Buteau S, et al. Medical costs of untreated anemia in elderly patients with predialysis chronic kidney disease. J Am Soc Nephrol 2006;17:3497-502 (Pubitemid 44865292)
22. St Peter WL, Khan SS, Ebben JP, et al. Chronic kidney disease: The distribution of health care dollars. Kidney Int 2004;66:313-21 (Pubitemid 38870108)
23. Trivedi H. Cost implications of caring for chronic kidney disease: Are interventions cost-effective? Adv Chronic Kidney Dis 2010;17:265-70
24. Magee JC, Barr ML, Basadonna GP, et al. Repeat organ transplantation in the United States, 1996-2005. Am J Transplant 2007;7:1424-33 (Pubitemid 46606945)
25. Vincenti F, Larsen C, Durrbach A, et al. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 2005;353:770-81 (Pubitemid 41215486)
26. Schnitzler MA, Lentine KL, Gheorghian A, et al. Renal function following living, standard criteria deceased and expanded criteria deceased donor kidney transplantation: Impact on graft failure and death. Transpl Int 2012; 25:179-91
27. Schnitzler MA, Lentine KL, Axelrod D, et al. Use of 12-month renal function and baseline clinical factors to predict long-term graft survival: Application to BENEFIT and BENEFIT-EXT trials. Transplantation 2012;93:172-81
28. Woodward RS, Schnitzler MA, Baty J, et al. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 2003;3:590-8 (Pubitemid 36612842)
29. Buchanan PM, Lentine KL, Burroughs TE, et al. Association of lower costs of pulsatile machine perfusion in renal transplantation from expanded criteria donors. Am J Transplant 2008;8:2391-401